Preferred Name |
Elvitegravir |
|
Synonyms |
6-(3-Chloro-2-fluorobenzyl)-1-((2S)-1-hydroxy-3-methylbutan-2-yl)-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid ELVITEGRAVIR Elvitegravir GS 9137 GS-9137 JTK 303 JTK-303 |
|
Definitions |
A modified quinolone antibiotic with activity against human immunodeficiency virus 1. Elvitegravir is an inhibitor of viral integrase and retains activity against integrase mutants that are resistant to Raltegravir. |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C76493 |
|
CAS_Registry |
697761-98-1 |
|
Chemical_Formula |
C23H23ClFNO5 |
|
code |
C76493 |
|
Concept_In_Subset | ||
Contributing_Source |
FDA |
|
DEFINITION |
A modified quinolone antibiotic with activity against human immunodeficiency virus 1. Elvitegravir is an inhibitor of viral integrase and retains activity against integrase mutants that are resistant to Raltegravir. |
|
FDA_UNII_Code |
4GDQ854U53 |
|
FULL_SYN |
6-(3-Chloro-2-fluorobenzyl)-1-((2S)-1-hydroxy-3-methylbutan-2-yl)-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid ELVITEGRAVIR Elvitegravir GS 9137 GS-9137 JTK 303 JTK-303 |
|
label |
Elvitegravir |
|
Legacy Concept Name |
Elvitegravir |
|
Preferred_Name |
Elvitegravir |
|
prefixIRI |
Thesaurus:C76493 |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C1701505 |
|
subClassOf |